FDA approves ivosidenib for advanced or metastatic cholangiocarcinoma

Oncology (Cancer)
FDA approves ivosidenib for advanced or metastatic cholangiocarcinoma

Source: FDA Center for Drug Evaluation and Research - What's New - August 26, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news